Table 2 |
||
|
Comparison of different prognosticators in single studies on breast cancer. |
||
|
LN + |
Prognosticator |
P value |
|
|
||
|
Kuopio et al. 1998 [34] |
||
|
1. Bcl-2 |
0.017 |
|
|
2. p53 |
0.121 |
|
|
3. Cystatin A |
0.386 |
|
|
Jalava et al. 2002 [16] |
||
|
1. ErbB2 |
0.0002 |
|
|
2. SMI |
0.0014 |
|
|
3. Bcl-2 |
0.048 |
|
|
Elzagheid et al. 2002 [150] |
||
|
1. E-cadherin |
0.0006 |
|
|
2. SMI |
0.0133 |
|
|
|
||
|
LN - |
||
|
|
||
|
Kuopio et al. 1998 [34] |
||
|
1. Cystatin A |
0.010 |
|
|
2. p53 |
0.021 |
|
|
3. Bcl-2 |
0.874 |
|
|
Jalava et al. 2002 [16] |
||
|
1. SMI |
0.0001 |
|
|
2. ErbB2 |
N.S. |
|
|
3. Bcl-2 |
N.S. |
|
|
Elzagheid et al. 2002 [150] |
||
|
1. SMI |
0.0299 |
|
|
2. E-cadherin |
0.5581 |
|
|
|
||
|
P values refer to the results of univariate analysis. Comparison of univariate analyses in a study allows one to conclude on the relative strengths of different prognosticators. |
||
|
Elzagheid et al. Diagnostic Pathology 2006 1:41 doi:10.1186/1746-1596-1-41 |
||